Skip to main content
. 2021 Dec 14;22(24):13416. doi: 10.3390/ijms222413416

Table 1.

Expression of CLDN6 in different cancer types.

Type of Cancer No. of Cases Positive Cases (%) References
Germ cell tumors 28 28 (100) [49]
Non-small-cell lung cancer 119 13 (10.9) [49]
355 23 (6.5) [51]
Breast cancer 70 1 (1.4) [49]
Oesophagus
Squamous cell carcinoma
19 0 (0) [49]
Gastric cancer 72 7 (9.7) [49]
494 255 (51.6) [52]
208 28 (13.5) [53]
Hepatocellular Carcinoma 48 0 (0) [49]
48 38 (79.2) [50]
Pancreas Adenocarcinoma 48 1 (2.1) [49]
Large intestine Adenocarcinoma 96 0 (0) [49]
Ovarian carcinoma 144 35 (24.3) [49]
62 34 (54.8) [54]
Endometrial Cancer 24 5 (20.8) [49]
173 47 (32.9) [55]
Cervical carcinoma 56 16 (28.6) [56]
Kidney carcinoma 48 0 (0) [49]
Bladder carcinoma 25 2 (8) [49]
Prostate Adenocarcinoma 47 0 (0) [49]
Skin tumors 24 0 (0) [49]
Atypical Teratoid/Rhabdoid Tumors 7 7 (100) [57]
59 17 (28.8) [58]
31 12 (38.7) [59]
Meningioma 10 1 (10) [59]
Myxofibrosarcoma 61 39 (63.9) [58,60]